Obstructive Sleep Apnea and Diabetic Nephropathy
Abd A. Tahrani(Heart of England NHS Foundation Trust), Martin J. Stevens(Heart of England NHS Foundation Trust), Safia Begum(Heartlands Hospital), Neil T. Raymond(University of Warwick), Kiran Dubb(University of Birmingham), Asad Ali(Heartlands Hospital), Anthony Barnett(University of Washington), Q. Altaf(Heart of England NHS Foundation Trust), Milan K. Piya(Warwickshire Hospital)
Cited by 126
Related Papers
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.1k
Diabetic neuropathy and oxidative stress
|Diabetes/Metabolism Research and Reviews|2006|286
Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy
|European Journal of Pharmacology|1999|235
An aldose reductase inhibitor reverses early diabetes‐induced changes in peripheral nerve function, metabolism, and antioxidative defense
|The FASEB Journal|2001|211
Obstructive Sleep Apnea and Diabetic Neuropathy: A Novel Association in Patients with Type 2 Diabetes
|American Journal of Respiratory and Critical Care Medicine|2012|194